Details
Specifications
Chemical identification
IUPAC NAME:
(5S,10S,10aR,14aS,15bS)-10,10a-Dihydroxy-7-methoxy-2,2-dimethyl-5-(2-methyl-1-propen-1-yl)-1,10,10a,14,14a,15b-hexahydro-12H-3,4-dioxa-5a,11a,15a-triazacycloocta[1,2,3-lm]indeno[5,6-b]fluorene-11,15(2 H,13H)-dione
Verruculogen is a tremorgenic mycotoxin, affecting CNS functions, arresting mammary carcinoma cells in vitro, affecting potassium channels. Verruculogen decreases GABA levels in CNS. Tremorgenic doses of verruculogen increase the number and decrease the affinity of DHP receptors in rat cortex. Verruculogen is a potent inhibitor of high conductance Ca activated K (maxi-K) channel.
Further Information
Soluble in benzene, ethyl acetate, and acetone; slightly soluble in ethanol; very soluble in CHCI;
Tremorgenic neurotoxin affecting central neural system.
Verruculogen decreases GABA levels in CNS. Tremorgenic doses of verruculogen increase the number and decrease the affinity of DHP receptors in rat cortex.Verruculogen is a potent inhibitor of high conductance Ca activated K (maxi-K) channel.
Warning or harmful
- Acute toxicity (oral, dermal, inhalation), category 4
- Skin irritation, categories 2, 3
- Eye irritation, category 2A
- Skin sensitization, category 1
- Specific target organ toxicity following single exposure, category 3
- Respiratory tract irritation
- Narcotic effects